Back to top
more

Chemours (CC)

(Delayed Data from NYSE)

$43.99 USD

43.99
1,464,930

+0.82 (1.90%)

Updated May 27, 2022 04:00 PM ET

After-Market: $43.98 -0.01 (-0.02%) 5:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.08%
2Buy18.56%
3Hold10.15%
4Sell5.79%
5Strong Sell2.83%
S&P50011.24%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value C Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (67 out of 253)

Industry: Chemical - Diversified

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for CC

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Assets          
Cash & Equivalents 1,451 1,105 943 1,201 1,556
Receivables 720 511 674 861 919
Notes Receivable 0 0 0 0 0
Inventories 1,099 939 1,079 1,147 935
Other Current Assets 75 78 81 84 83
Total Current Assets 3,345 2,633 2,777 3,293 3,493
Net Property & Equipment 3,154 3,474 3,559 3,291 3,008
Investments & Advances 169 167 162 160 173
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 108 167 174 181 166
Deposits & Other Assets 547 405 292 437 453
Total Assets 7,550 7,082 7,258 7,362 7,293
Liabilities & Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Notes Payable 0 0 0 0 0
Accounts Payable 1,162 844 923 1,137 1,075
Current Portion Long-Term Debt 25 21 134 13 15
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 325 577 484 559 558
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 346 0 0 0 0
Total Current Liabilities 1,858 1,442 1,541 1,709 1,648
Mortgages 0 0 0 0 0
Deferred Taxes/Income 49 36 118 217 208
Convertible Debt 0 0 0 0 0
Long-Term Debt 3,724 4,005 4,026 3,959 4,097
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 658 590 633 457 475
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 6,468 6,267 6,563 6,342 6,428
Shareholders Equity 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 944 890 859 860 837
Retained Earnings 1,746 1,303 1,249 1,466 579
Other Equity -363 -308 -343 -558 -437
Treasury Stock 1,247 1,072 1,072 750 116
Total Shareholder's Equity 1,082 815 695 1,020 865
Total Liabilities & Shareholder's Equity 7,550 7,082 7,258 7,362 7,293
Total Common Equity 1,082 815 695 1,020 865
Shares Outstanding 162.96 164.50 163.50 171.00 185.10
Book Value Per Share 6.64 4.95 4.25 5.96 4.67

Fiscal Year End for The Chemours Company falls in the month of December.

All items in Millions except Per Share data.

3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Assets          
Cash & Equivalents 1,145 1,451 1,031 1,139 1,008
Receivables 1,014 720 831 802 723
Notes Receivable 0 0 0 0 0
Inventories 1,166 1,099 1,016 1,046 988
Other Current Assets 68 75 493 60 67
Total Current Assets 3,393 3,345 3,371 3,047 2,786
Net Property & Equipment 3,131 3,154 3,127 3,448 3,432
Investments & Advances 170 169 190 178 169
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 0 0 0 0 0
Intangibles 107 108 110 162 163
Deposits & Other Assets 498 547 519 414 392
Total Assets 7,524 7,550 7,530 7,479 7,170
Liabilities & Shareholders Equity 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Notes Payable 0 0 0 0 0
Accounts Payable 1,168 1,162 1,085 1,061 976
Current Portion Long-Term Debt 206 25 25 25 23
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 302 325 361 321 502
Income Taxes Payable 0 0 0 0 0
Other Current Liabilities 99 346 308 267 0
Total Current Liabilities 1,775 1,858 1,779 1,674 1,501
Mortgages 0 0 0 0 0
Deferred Taxes/Income 52 49 57 55 51
Convertible Debt 0 0 0 0 0
Long-Term Debt 3,692 3,724 3,829 3,964 3,970
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 653 690 698 610
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 6,357 6,468 6,531 6,579 6,318
Shareholders Equity 3/31/2022 12/31/2021 9/30/2021 6/30/2021 3/31/2021
Preferred Stock 0 0 0 0 0
Common Stock (Par) 2 2 2 2 2
Capital Surplus 956 944 926 920 907
Retained Earnings 1,940 1,746 1,554 1,381 1,357
Other Equity -338 -363 -331 -316 -342
Treasury Stock 1,393 1,247 1,152 1,087 1,072
Total Shareholder's Equity 1,167 1,082 999 900 852
Total Liabilities & Shareholder's Equity 7,524 7,550 7,530 7,479 7,170
Total Common Equity 1,167 1,082 999 900 852
Shares Outstanding 155.47 162.96 165.10 165.10 165.50
Book Value Per Share 7.51 6.64 6.05 5.45 5.15